Greece approved colchicine, an inexpensive medicine for heart diseases, to be included in the protocol of oral treatments for patients with Covid-19.
The committee of experts of the health ministry gave the “green light” after the positive results of a large Canadian study in which Greece participated.
The study showed that the administration of colchicine to Covid-19 patients “reduced mortality by 44%, hospitalization by 25% and the need for intubation by 50%,” professor of cardiology Spyros Deftereos, who coordinated the study in Greece told Athens-Macedonia News Agency (AMNA).
